A Drug Interaction Study of 31001074 and Paroxetine in Healthy Volunteers

Phase 1 Completed 14 enrolled Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

NaSingle-groupOpen-label

Summary

The purpose of this study is to determine the concentration of 31001074 in blood samples from healthy volunteers who have been administered 31001074 and paroxetine.

Timeline

Start: 2010-08
Primary completion: —
Completion: 2010-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	31001074	Unknown	—	Oral
Subject	Paroxetine	Small molecule	20 mg	Oral

Indications

No indication recorded.